Product image of Orelox (Cefpodoxime Proxetil) supplied by GNH India

Orelox

Active Ingredient:
Cefpodoxime Proxetil
Origin:
EU

Orelox (Cefpodoxime Proxetil)

Cefpodoxime proxetil, the active ingredient in Orelox, is a cephalosporin antibiotic presented as an oral tablet for systemic use. It treats bacterial infections in adults and children when prescribed by a healthcare professional.

GNH India supplies Orelox as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Teofarma S.R.L.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Cefpodoxime proxetil is a broad‑spectrum oral cephalosporin used for infections affecting various body systems:

  • Acute bacterial sinusitis: helps relieve sinus inflammation and discharge.
  • Uncomplicated urinary tract infection: eradicates common uropathogens.
  • Community‑acquired pneumonia: targets typical respiratory pathogens.
  • Skin and soft‑tissue infections: reduces bacterial load in cellulitis and abscesses.
  • Pharyngitis/tonsillitis: treats streptococcal throat infections.
  • Otitis media: combats middle‑ear bacterial infection.

How It Works

  • Cefpodoxime proxetil is a third‑generation cephalosporin that binds to penicillin‑binding proteins on bacterial cell walls, inhibiting the final stages of peptidoglycan cross‑linking. This disruption weakens the wall, leading to osmotic instability and bacterial cell lysis, which stops the infection from progressing.

Side Effects

Adverse reactions to cefpodoxime proxetil vary in frequency and severity.

Common Side Effects

  • Diarrhea: mild to moderate loose stools.
  • Nausea: occasional feeling of queasiness.
  • Headache: transient head discomfort.
  • Rash: mild skin erythema.
  • Abdominal pain: cramp‑like discomfort.
  • Vaginal candidiasis: yeast infection in some women.

Serious or Rare Side Effects

  • Anaphylaxis: severe, potentially life‑threatening allergic reaction.
  • Stevens‑Johnson syndrome: rare severe skin disorder.
  • Clostridioides difficile‑associated colitis: severe intestinal inflammation.
  • Hemolytic anemia: destruction of red blood cells.
  • Liver enzyme elevation: abnormal liver function tests.
  • Neutropenia: low neutrophil count increasing infection risk.

Precautions & Warnings

Cefpodoxime proxetil should be used with consideration of patient‑specific factors and proper handling.

  • Renal impairment: adjust dose in patients with reduced kidney function.
  • Hepatic disease: monitor liver function during therapy.
  • History of hypersensitivity: avoid if allergic to cephalosporins or penicillins.
  • Concomitant antibiotics: assess for additive antimicrobial effect.
  • Pregnancy and lactation: weigh benefits against potential risks.
  • Store below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Avoid Interactions

Cefpodoxime proxetil may interact with several medicines, requiring attention to the interaction level.

Major Interactions (Avoid)

  • Probenecid: may increase cefpodoxime plasma concentrations, raising toxicity risk.
  • Warfarin: potential enhancement of anticoagulant effect, requiring INR monitoring.

Moderate Interactions (Monitor Closely)

  • Oral antacids containing aluminum or magnesium: can reduce cefpodoxime absorption.
  • Metformin: may increase metformin plasma levels in renal impairment.
  • Oral contraceptives: possible reduction in contraceptive efficacy.
  • Diuretics: monitor electrolyte balance when combined with cefpodoxime.
  • Statins: observe for increased risk of muscle toxicity.

Frequently Asked Questions

Orelox contains cefpodoxime proxetil, a third‑generation cephalosporin antibiotic that is prescribed to treat a range of bacterial infections such as sinusitis, community‑acquired pneumonia, uncomplicated urinary tract infections, skin‑soft‑tissue infections, pharyngitis and otitis media when the infecting organisms are susceptible.

Cefpodoxime proxetil inhibits bacterial cell‑wall synthesis by binding to penicillin‑binding proteins, preventing the cross‑linking of peptidoglycan strands. This weakens the wall, causing osmotic rupture and bacterial death, which stops the infection from spreading.

The dose of Orelox is determined by the prescribing clinician based on the type and severity of infection, patient age, weight and renal function. Healthcare providers set the appropriate regimen and duration according to clinical guidelines.

Cefpodoxime proxetil is classified as pregnancy category B in the EU, indicating no evidence of risk in animal studies but limited human data. It may be used during pregnancy or lactation only if the potential benefit justifies the potential risk; the prescriber should evaluate each case individually.

To order Orelox, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.

Compared with earlier‑generation oral cephalosporins, cefpodoxime offers broader activity against Gram‑negative organisms and improved stability against ß‑lactamases. It provides once‑daily dosing for many infections, which can enhance patient adherence relative to twice‑daily agents like cefuroxime.

Orelox tablets should be stored below 25 °C in their original container, protected from moisture and direct sunlight. Keep the packaging tightly closed and out of reach of children.

Orelox is taken orally, usually with a glass of water. It may be taken with or without food, but consistent intake with respect to meals helps maintain stable absorption.

Serious adverse reactions include severe allergic responses such as anaphylaxis, rare skin conditions like Stevens‑Johnson syndrome, Clostridioides difficile‑associated colitis, and blood disorders such as hemolytic anemia or neutropenia. Patients should seek immediate medical attention if they experience rash, fever, persistent diarrhea or signs of an allergic reaction.

Individuals with a known hypersensitivity to cefpodoxime, other cephalosporins, or penicillins should avoid Orelox. Caution is also advised for patients with severe renal impairment, those with a history of severe allergic reactions, and anyone currently experiencing a serious infection that requires a different class of antibiotic.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Cefpodoxime Proxetil

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT